Decreasing iron neurotoxicity in pantothenate kinase-associated neurodegeneration

Grants

Funding Acknowledgements

SA and AIB report research grants from the Australian National Health and Medical Research Council and the US National Institutes of Health, relevant to this work. AIB is a shareholder in Alterity Ltd, Cogstate Ltd, Brighton Biotech LLC, Grunbiotics Pty Ltd, Eucalyptus Pty Ltd, and Mesoblast Ltd. He is a paid consultant for, and has a profit share interest in, Collaborative Medicinal Development Pty Ltd.